report from Biotechnica

Better single-use cross flow techs still needed says GE Healthcare

By Gareth Macdonald

- Last updated on GMT

Still work to be done downstream says GE Healthcare expert
Still work to be done downstream says GE Healthcare expert

Related tags Biotechnology

The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.

Call for topics

What do you think?

In which areas of the biopharmaceutical manufacturing process are new, better technologies needed?

Is connecting systems provided by different suppliers your biggest headache or do you hanker for improved chromatography systems?

Are today's cell lines good enough or do you think developers could do more?

BioPharma-reporter.com invites readers to suggest topics for future podcasts via the comment box below.

Related news

Show more

Related products

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...